Best Choice Effervescent Antacid Pain Relief Tablet, Effervescent
NDC Package 63941-421-36
Package Information
Best Choice Effervescent Antacid Pain Relief (aspirin, citric acid, sodium bicarbonate) tablets is ■ do not exceed recommended dosage■ to avoid serious injury, completely dissolve tablets in 4 oz. This formulation utilizes a tablet, effervescent delivery system. Marketed by Valu Merchandisers Company, this product is identified by NDC 63941-421 and is authorized under FDA application M013.
Identification & Billing
- RxCUI: 1536675 - aspirin 325 MG / citric acid 1000 MG / sodium bicarbonate 1916 MG Effervescent Oral Tablet
- RxCUI: 1536675 - ASA 325 MG / Citric Acid 1000 MG / NaHCO3 1916 MG Effervescent Oral Tablet
Clinical Specifications
- Oral - Administration to or by way of the mouth.
- Oral - Administration to or by way of the mouth.
- Acidifying Activity - [MoA] (Mechanism of Action)
- Alkalinizing Activity - [MoA] (Mechanism of Action)
- Anti-Inflammatory Agents, Non-Steroidal - [CS]
- Anti-coagulant - [EPC] (Established Pharmacologic Class)
- Calcium Chelating Activity - [MoA] (Mechanism of Action)
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
- Decreased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Decreased Platelet Aggregation - [PE] (Physiologic Effect)
- Decreased Prostaglandin Production - [PE] (Physiologic Effect)
- Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
- Platelet Aggregation Inhibitor - [EPC] (Established Pharmacologic Class)
- Acidifying Activity - [MoA] (Mechanism of Action)
- Alkalinizing Activity - [MoA] (Mechanism of Action)
- Anti-Inflammatory Agents, Non-Steroidal - [CS]
- Anti-coagulant - [EPC] (Established Pharmacologic Class)
- Calcium Chelating Activity - [MoA] (Mechanism of Action)
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
- Decreased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Decreased Platelet Aggregation - [PE] (Physiologic Effect)
- Decreased Prostaglandin Production - [PE] (Physiologic Effect)
- Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
- Platelet Aggregation Inhibitor - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 63941 - Valu Merchandisers Company
- 63941-421 - Best Choice Effervescent Antacid Pain Relief
- 63941-421-36 - 18 POUCH in 1 CARTON / 2 TABLET, EFFERVESCENT in 1 POUCH
- 63941-421 - Best Choice Effervescent Antacid Pain Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (63941-421). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63941-421-36 identifies a specific commercial package of 18 pouch in 1 carton / 2 tablet, effervescent in 1 pouch of Best Choice Effervescent Antacid Pain Relief, a human over the counter drug labeled by Valu Merchandisers Company. This tablet, effervescent is formulated for oral use and contains anhydrous citric acid; aspirin; sodium bicarbonate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Valu Merchandisers Company on August 30, 2013.
How is this Valu Merchandisers Company product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63941042136. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.